BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension

by Bajwa, A.A, Burger, C.D, Deng, C., Desai, S.V, Eggert, M.S, El-Kersh, K.A, Fisher, M.R, Johri, S., Joly, J.M, Mehta, J., Miceli, M., Palevsky, H.I, Ramani, G.V, Restrepo-Jaramillo, R., Sahay, S., Shah, T.G, Shapiro, S.M, Smith, P., Spikes, L.A
Published 2022